View profile

MoEngage gets $25m funding; Coronavirus hits dealmaking & IPOS

Revue
 
Good morning, Here's your Wednesday edition of Asia AI News! As more than 300 Chinese companies seek
 
February 12 · Issue #184 · View online
Asia AI News
Good morning,
Here’s your Wednesday edition of Asia AI News!
As more than 300 Chinese companies seek loans to offset the effect of the coronavirus crisis, Megvii has apparently applied for 100 million yuan to improve the accuracy of facial recognition technology when identifying masked individuals in crowds.
Megvii, you will remember, has postponed its IPO on HKEX a number of times over the past year, eventually receiving clearance from the exchange mid-January. In light of the growing virus crisis, an IPO now seems unlikely in the short term.
According to the FT, China’s IPO activity has slowed to a trickle and all M&A deal-making is at a standstill. So, it’s hard to imagine that Chinese venture capital funding - both inward and outward - will have not also ground to a halt.
Have a good day!
/Carrington

Startup News
MoEngage gets $25 million in Series C funding MoEngage gets $25 million in Series C funding
AI Chips
Arm launches new AI chip for small devices and sensors
Facial Recognition
LG CNS deploys AI facial recognition gate service
Healthcare
AI bolsters radiologists’ ability to pinpoint breast cancer
Coronavirus
Coronavirus epidemic hits China dealmaking and IPOs
Hundreds of Chinese businesses seek billions in loans to contend with coronavirus
China tech giants chip in to combat coronavirus, global events impacted
Coronavirus researchers are using high-tech methods to predict where the virus might go next
China has launched an app so people can check their risk of catching the coronavirus
US-China Trade War
How 4 Chinese hackers allegedly took down Equifax How 4 Chinese hackers allegedly took down Equifax
China denies US hacking allegations
Germany set to follow UK on Huawei conundrum – report
German decision on Huawei 5G 'imminent,' says ambassador
Follow Asia AI News on Twitter
Did you enjoy this issue?
If you don't want these updates anymore, please unsubscribe here.
If you were forwarded this newsletter and you like it, you can subscribe here.
Powered by Revue